ChiehHan Lee - Taiyen Biotech VP Department
| 1737 Stock | TWD 32.20 0.05 0.16% |
Insider
ChiehHan Lee is VP Department of Taiyen Biotech Co
| Phone | 886 6 2160 688 |
| Web | https://www.tybio.com.tw |
Taiyen Biotech Management Efficiency
The company has return on total asset (ROA) of 0.0346 % which means that it generated a profit of $0.0346 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0642 %, meaning that it generated $0.0642 on every $100 dollars invested by stockholders. Taiyen Biotech's management efficiency ratios could be used to measure how well Taiyen Biotech manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 6 records | INSIDER Age | ||
| PoYa Wang | Tainan Enterprises Co | N/A | |
| INeng Yu | De Licacy Industrial | N/A | |
| YuechO Wang | Tainan Enterprises Co | N/A | |
| Ching Yang | Tainan Enterprises Co | 72 | |
| Mike Wu | Tainan Enterprises Co | N/A | |
| WeiLi Yeh | De Licacy Industrial | N/A | |
Management Performance
| Return On Equity | 0.0642 | |||
| Return On Asset | 0.0346 |
Taiyen Biotech Leadership Team
Elected by the shareholders, the Taiyen Biotech's board of directors comprises two types of representatives: Taiyen Biotech inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Taiyen. The board's role is to monitor Taiyen Biotech's management team and ensure that shareholders' interests are well served. Taiyen Biotech's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Taiyen Biotech's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Wei Su, Director Department | ||
| MeiYu Chuang, Chief Auditor | ||
| MeiWen Chen, Director Department | ||
| TungHsuan Yang, Director Office | ||
| ShiHui Chen, President | ||
| ChiehHan Lee, VP Department |
Taiyen Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Taiyen Biotech a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0642 | |||
| Return On Asset | 0.0346 | |||
| Profit Margin | 0.11 % | |||
| Operating Margin | 0.12 % | |||
| Current Valuation | 4.82 B | |||
| Shares Outstanding | 200 M | |||
| Shares Owned By Insiders | 48.28 % | |||
| Shares Owned By Institutions | 5.34 % | |||
| Price To Earning | 14.76 X | |||
| Price To Book | 1.00 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Taiyen Stock Analysis
When running Taiyen Biotech's price analysis, check to measure Taiyen Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Taiyen Biotech is operating at the current time. Most of Taiyen Biotech's value examination focuses on studying past and present price action to predict the probability of Taiyen Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Taiyen Biotech's price. Additionally, you may evaluate how the addition of Taiyen Biotech to your portfolios can decrease your overall portfolio volatility.